BioPacific Conference 2011 Agenda

Theme: Emerging Trends and Opportunities in the Biopharmaceutical Industries of the US, China, and Beyond

June 25, 2011, Saturday, Foster City, California

8:00 – 9:00am Registration and Vendor Exhibits
9:00 – 9:05am Welcome Remarks
Janet Xiao, CABS President-Elect, Partner, Morrison & Foerster LLP
9:05 – 9:15am State of the Society
Wei Dong, CABS President, Global Biometrics Head Asia Pacific, Roche
  Session I: Emerging Trends in the Biopharmaceutical Industry
Session Chairs: Cheni Kwok and Shichang Miao

9:15 – 9:40am Douglass Given, Investment Partner, Managing Director and Founder, Bay City Capital
“Emerging Trends in the Biopharmaceutical Industry”
9:40 – 10.05am John Oyler, Founder and CEO of BeiGene, China
“New Paradigms for Biopharmaceutical Research and Development in China”
10:05 – 10.30am Don Ganem VP and Global Head of Infectious Disease, Novartis Institutes of Biomedical Research
10:30 – 10:50am Chuck Comey, Partner, Morrison & Foerster LLP, Platinum Sponsor
10:50 – 11:10am Break, Networking, and Vendor Exhibits
  Session II: New Waves of Drug Discovery and Commercialization
Session Chairs: Charlene Liao and John Mao

11:10 – 11:35am Napoleone Ferrara, Genentech Fellow, Genentech
“New Insights into the Regulation of Angiogenesis”
11:35 – 12:00am Neil Desai, Senior VP, Abraxis BioScience LLC, Celgene
“Nanotechnology from Bench to the Clinic and Beyond”
12:00 – 12:25pm Stephen K. Doberstein, Senior VP and Chief Scientific Officer, Nektar Therapeuticsh
“New Promises with Polymer-Drug Conjugates”
12:25 – 12:35pm Connie Sun, Senior VP of Oncology Chemistry, Pharmaron, Gold Sponsor
12:35 – 12:45pm Jun Li, Chief Scientific Officer, Abgent, Gold Sponsor
12:45 – 1:45pm Lunch
  Session III: Global Clinical Development and Product Registration

Session Chairs: Wei Dong, Josh Xiao and Charles Liu

1:45 – 2:10pm Frank Shen, Divisional VP of Global Data Management and Statistics, Pharmaceutical R&D, Abbott Laboratories
“A Bridge Too Far? Challenges and Opportunities in Linking China into Simultaneous Global Development via Multi-Regional Clinical Trials”
2:10 – 2:35pm Albert Liou, Vice President and General Manager, PAREXEL International
“Prospect of Global Clinical Development Next 10 Years: Asia’s Roles”
2:35 – 3:00pm Wen Chen, VP of Business Development, TigerMed Consulting, China
3:00 – 3:10pm Cassandra Boyer, Regional Sales Director, GE Healthcare, Gold Sponsor
3:10 – 3:20pm Hui Li, Director of Business Development, PPD/BioDuro, Gold Sponsor
3:20 – 3:40pm Break, Networking, and Vendor Exhibits
  Session IV: China’s Future in Life Sciences: New Drivers of Innovation
Session Chairs: Chi-Hui Tang and Alan Hao

3:40 – 4:00pm Michael Zielenziger, Consultant, Monitor Group
“China’s Future in Life Sciences: New Drivers of Innovation”
4:00 – 4:20pm Sofie Qiao, President, CEO and Co-Founder, LINQ Pharmaceuticals
“A Nuanced Balance”
4:20 – 4:40pm Xiaodong Yang, President and CEO, Apexigen
“Managing Strategic Alliances with Partners in China: Apexigen’s Experience”
4:40 – 5:00pm Reinhard Oesterle, Senior Director of Business Development, SciClone Pharmaceuticals
“Building a Leading Specialty Pharma Company in China”
5:00 – 5:10pm Peter Zhang, CEO, GenePharma, Gold Sponsor
5:10 – 5:40pm Panel Discussion
5:40 – 6:00pm Break, Networking, and Vendor Exhibits
6:00 – 7:00pm Dinner
  Session V: Crossing the Bridge: Opportunities and Lessons Learned
Session Chairs: Hua Tu and Yibing Wang

7:00 – 7:15pm Joy Zhu, Senior VP of Global Clinical Development, S*BIO, Singapore
“Leveraging Geographic Location and Development Talent in Drug Developmet – A S*BIO Story”
7:15 – 7:30pm Joyce Peng, Marketing Director, BGI Americas Corporation
“Partnering for Multi-omics Excellence”
7:30 – 7:45pm Andrew Wong, Director of Corporate Development, Alexza Pharmaceuticals, Inc.
“Efficient Creation of Differentiated Therapies-Alexza Pharmaceuticals & the Staccato System”
7:45 – 8:00pm Dongxiao Zhang, President and CEO, Formurex
“Channeling the New Wave of Chinese Pharmaceutical Products to the US Market”
8:00 – 8:15pm John Wang, President and CEO, ImmuOn, China
“China: The Road to Home”
8:15 – 8:30pm Hua Tu, President and CEO, LakePharma, Inc.
“Large Molecule Drug Development in China”
8:30 – 9:00pm Panel Discussion
9:00pm Adjourned